Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ACURA PHARMACEUTICALS, INC | Financial_Report.xls |
| EX-32 - EXHIBIT 32 - ACURA PHARMACEUTICALS, INC | v400005_ex32.htm |
| EX-10.9 - EXHIBIT 10.9 - ACURA PHARMACEUTICALS, INC | v400005_ex10-9.htm |
| EX-31.1 - EXHIBIT 31.1 - ACURA PHARMACEUTICALS, INC | v400005_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ACURA PHARMACEUTICALS, INC | v400005_ex31-2.htm |
| EX-10.8 - EXHIBIT 10.8 - ACURA PHARMACEUTICALS, INC | v400005_ex10-8.htm |
| EX-10.10 - EXHIBIT 10.10 - ACURA PHARMACEUTICALS, INC | v400005_ex10-10.htm |
| EX-10.13 - EXHIBIT 10.13 - ACURA PHARMACEUTICALS, INC | v400005_ex10-13.htm |
| 10-K - FORM 10-K - ACURA PHARMACEUTICALS, INC | v400005_10k.htm |
| EX-10.11 - EXHIBIT 10.11 - ACURA PHARMACEUTICALS, INC | v400005_ex10-11.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Acura Pharmaceuticals, Inc.
Palatine, Illinois
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-195612, 333-151653, 333-151620, 333-133172, 333-123615, 333-63288, and 33-98356) and on Form S-3 (Nos. 333-187075 and 333-146416) of Acura Pharmaceuticals, Inc. of our report dated March 2, 2015, relating to the consolidated financial statements, which appear in this Form 10-K.
| /s/ BDO USA, LLP | |
| Chicago, Illinois | |
| March 2, 2015 |